T. Rowe Price Associates’s Nuvectra Corporation Common Stock NVTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-53,643
Closed -$73K – 2587
2019
Q3
$73K Sell
53,643
-37,700
-41% -$73.9K ﹤0.01% 2473
2019
Q2
$306K Buy
91,343
+19,502
+27% +$123K ﹤0.01% 2294
2019
Q1
$791K Buy
71,841
+24,410
+51% +$329K ﹤0.01% 1939
2018
Q4
$775K Buy
47,431
+5,120
+12% +$97.9K ﹤0.01% 1910
2018
Q3
$930K Sell
42,311
-9,318
-18% -$179K ﹤0.01% 1905
2018
Q2
$1.06M Buy
51,629
+12,686
+33% +$214K ﹤0.01% 1813
2018
Q1
$507K Sell
38,943
-33,200
-46% -$337K ﹤0.01% 2080
2017
Q4
$560K Buy
72,143
+60
+0.1% +$630 ﹤0.01% 2050
2017
Q3
$956K Sell
72,083
-4,200
-6% -$49.7K ﹤0.01% 1829
2017
Q2
$1.01M Sell
76,283
-1,200
-2% -$11.4K ﹤0.01% 1779
2017
Q1
$529K Sell
77,483
-5,200
-6% -$35.5K ﹤0.01% 2041
2016
Q4
$416K Hold
82,683
– – ﹤0.01% 2130
2016
Q3
$572K Sell
82,683
-23
-0% -$158 ﹤0.01% 1959
2016
Q2
$612K Buy
+82,706
New +$659K ﹤0.01% 1887

Other funds holding NVTR

T. Rowe Price Associates's NVTR Position: Q4 2019 in Review

T. Rowe Price Associates sold out of Nuvectra Corporation Common Stock (NVTR) in Q4 2019, closing a stake of 53,643 shares — an estimated $73K sold.

T. Rowe Price Associates first reported a position in NVTR in Q2 2016 and held it in 14 quarters. The position peaked at $1.06M in Q2 2018. 7 funds tracked by Wall St. Rank hold NVTR as of Q4 2019.

  • T. Rowe Price Associates reported no remaining Nuvectra Corporation Common Stock position as of Q4 2019 after selling out during the quarter.
  • T. Rowe Price Associates sold 53,643 Nuvectra Corporation Common Stock shares in Q4 2019, an estimated $73K.
  • T. Rowe Price Associates first reported a position in Nuvectra Corporation Common Stock in Q2 2016 and held it in 14 quarters.
  • T. Rowe Price Associates's Nuvectra Corporation Common Stock position peaked at $1.06M in Q2 2018.
  • 7 funds tracked by Wall St. Rank held Nuvectra Corporation Common Stock as of Q4 2019.

Based on T. Rowe Price Associates's 13F filing for Q4 2019, filed 14 Feb 2020.